|
S/nos.
|
MW
|
HBA
|
HBD
|
mlogP
|
SA
|
ABS
|
Lipinski violation
|
Drug likeness
|
|---|
|
1.
|
514.61
|
6
|
1
|
3.49
|
4.83
|
0.55
|
1
|
Yes
|
|
2.
|
542.67
|
6
|
1
|
3.86
|
5.07
|
0.55
|
1
|
Yes
|
|
3.
|
557.68
|
6
|
1
|
3.34
|
5.24
|
0.55
|
1
|
Yes
|
|
4.
|
529.63
|
6
|
2
|
2.97
|
4.99
|
0.55
|
1
|
Yes
|
|
5.
|
583.72
|
6
|
1
|
3.7
|
4.96
|
0.55
|
1
|
Yes
|
|
6.
|
530.61
|
7
|
1
|
2.97
|
4.51
|
0.55
|
1
|
Yes
|
|
7.
|
543.65
|
6
|
1
|
3.15
|
4.66
|
0.55
|
1
|
Yes
|
|
8.
|
571.71
|
6
|
1
|
3.52
|
4.91
|
0.55
|
1
|
Yes
|
|
9.
|
569.69
|
6
|
1
|
3.52
|
4.83
|
0.55
|
1
|
Yes
|
|
10.
|
543.65
|
6
|
1
|
3.15
|
4.7
|
0.55
|
1
|
Yes
|
|
11.
|
559.65
|
8
|
2
|
2.38
|
5.15
|
0.55
|
1
|
Yes
|
|
12.
|
587.71
|
7
|
2
|
2.74
|
5.4
|
0.55
|
1
|
Yes
|
- MW, molecular weight; HBA, hydrogen bond acceptors; HBD, hydrogen bond donors; SA, synthetic accessibility; ABS, Bioavailability Score
